e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
COPD - diagnosis and staging III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiointervalography in COPD patients with concomitant coronary heart disease
M. Y. Klishina, E. S. Korotkova, O. V. Aleksandrov, S. P. Grigoriev, E. O. Loshkareva, M. V. Gurevich (Moscow, Russian Federation)
Source:
Annual Congress 2005 - COPD - diagnosis and staging III
Session:
COPD - diagnosis and staging III
Session type:
Thematic Poster Session
Number:
3324
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Y. Klishina, E. S. Korotkova, O. V. Aleksandrov, S. P. Grigoriev, E. O. Loshkareva, M. V. Gurevich (Moscow, Russian Federation). Cardiointervalography in COPD patients with concomitant coronary heart disease. Eur Respir J 2005; 26: Suppl. 49, 3324
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2002; 20: Suppl. 38, 247s
Year: 2002
COPD phenotypes not linked to increased risk of coronary heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019
Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Underappreciation of coronary artery disease in patients with COPD
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020
The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013
COPD in heart failure patients
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD)
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Ischemic heart disease in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 706s
Year: 2007
The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006
Lung diffusion capacity is reduced in patients with coronary artery disease and no signs of heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 406s
Year: 2006
The heart rate variability in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - COPD
Year: 2008
Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Lipid profile in COPD patients with coronary artery disease comorbidity
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Cardiac effects of tiotropium bromide in patients with chronic obstructive pulmonary disease and coronary artery disease
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006
Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure
Source: International Congress 2019 – More and more COPD
Year: 2019
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010
Underestimation of bronchial obstruction in patients with coronary heart disease and cardiac insufficiency
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017
Heart failure and coronary artery disease in lung disease
Source: International Congress 2018 – PG19 Heart-lung interaction
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept